ERBB2 and invasive breast carcinoma: Recently, on the basis of the microarray profiling of invasive breast carcinomas, five distinct subtypes of tumors (luminal A, luminal B, normal breast-like, HER-2/neu overexpressing, and basal) associated with different clinical outcomes have been identified [29,30].